Attached files
| file | filename |
|---|---|
| EX-99.1 - SWK Holdings Corp | e00131_ex99-1.htm |
| 10-K - SWK Holdings Corp | e00131_swk-10k.htm |
| EX-32.02 - SWK Holdings Corp | e00131_ex32-02.htm |
| EX-23.01 - SWK Holdings Corp | e00131_ex23-01.htm |
| EX-21.01 - SWK Holdings Corp | e00131_ex21-01.htm |
| EX-31.02 - SWK Holdings Corp | e00131_ex31-02.htm |
| EX-32.01 - SWK Holdings Corp | e00131_ex32-01.htm |
| EX-31.01 - SWK Holdings Corp | e00131_ex31-01.htm |
EXHIBIT 23.02
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements of SWK Holdings Corporation on Form S-3 (Nos. 333-147975, 333-145742, 333-113899, 333-110248, 333-77068, 333-68342 and 33-46624) and Form S-8 (Nos. 333-150944, 333-142745, 333-136705, 333-113914, 333-104711, 333-64552, 333-59842, 333-55822, 333-35730, 333-32460, 333-93591, 333-92159, 333-87505 and 333-208500) of our report dated March 14, 2016 on our audits of the financial statements of Holmdel Pharmaceuticals, LP as of December 31, 2015 and 2014 and for each of the years then ended, which report is included in this Annual Report on Form 10-K to be filed on or about March 23, 2016.
/s/ EISNERAMPER LLP
Iselin, New Jersey
March 23, 2016